1. Home
  2. RDWR vs ELVN Comparison

RDWR vs ELVN Comparison

Compare RDWR & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDWR
    SELLHOLDBUYas of a day ago
  • ELVN
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • RDWR 1996
  • ELVN 2016
  • Country
  • RDWR Israel
  • ELVN United States
  • Employees
  • RDWR N/A
  • ELVN N/A
  • Industry
  • RDWR EDP Services
  • ELVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • RDWR Technology
  • ELVN Health Care
  • Exchange
  • RDWR Nasdaq
  • ELVN Nasdaq
  • Market Cap
  • RDWR 889.9M
  • ELVN 1.1B
  • IPO Year
  • RDWR 1999
  • ELVN 2020
  • Fundamental
  • Price
  • RDWR $19.76
  • ELVN $18.69
  • Analyst Decision
  • RDWR Hold
  • ELVN Strong Buy
  • Analyst Count
  • RDWR 4
  • ELVN 5
  • Target Price
  • RDWR $27.00
  • ELVN $38.20
  • AVG Volume (30 Days)
  • RDWR 132.1K
  • ELVN 287.3K
  • Earning Date
  • RDWR 05-07-2025
  • ELVN 05-13-2025
  • Dividend Yield
  • RDWR N/A
  • ELVN N/A
  • EPS Growth
  • RDWR N/A
  • ELVN N/A
  • EPS
  • RDWR 0.14
  • ELVN N/A
  • Revenue
  • RDWR $274,880,000.00
  • ELVN N/A
  • Revenue This Year
  • RDWR $9.54
  • ELVN N/A
  • Revenue Next Year
  • RDWR $7.54
  • ELVN N/A
  • P/E Ratio
  • RDWR $141.14
  • ELVN N/A
  • Revenue Growth
  • RDWR 5.20
  • ELVN N/A
  • 52 Week Low
  • RDWR $16.12
  • ELVN $15.96
  • 52 Week High
  • RDWR $25.00
  • ELVN $30.03
  • Technical
  • Relative Strength Index (RSI)
  • RDWR 30.83
  • ELVN 39.59
  • Support Level
  • RDWR $22.07
  • ELVN $18.36
  • Resistance Level
  • RDWR $22.23
  • ELVN $20.33
  • Average True Range (ATR)
  • RDWR 0.58
  • ELVN 1.31
  • MACD
  • RDWR -0.21
  • ELVN -0.18
  • Stochastic Oscillator
  • RDWR 3.69
  • ELVN 12.28

Stock Price Comparison Chart: RDWR vs ELVN

RDWR
ELVN
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April051015202530354045RDWR VS ELVN

About RDWR Radware Ltd.

Radware Ltd provides cyber security and application delivery solutions. The company provides solutions for cloud, on-premises, and software-defined data centers (SDDC). The solutions of the company secure the digital experience by providing infrastructure, application, and network protection and availability services to enterprises globally. The business segments of the company are Radware's Core Business and The Hawks' Business. The company derives maximum revenue from Radware's Core Business. The company generates maximum revenue from the United States.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use